Hikma Pharmaceuticals USA Inc. recalls Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, N…
- Recall date
- July 22, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0551-2025
- FDA classification
- Class II
- Brand / firm
- Hikma Pharmaceuticals USA Inc.
- Sold / distributed
- Distributed Nationwide in the USA
Why it was recalled
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Get recall alerts
Free email alert whenever Hikma Pharmaceuticals USA Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hikma Pharmaceuticals USA Inc.